MR spectroscopy of head and neck cancer, European Journal of Radiology, vol.82, pp.982-989, 2013. ,
Increase in signal-to-noise ratio of O10,000 times in liquid-state NMR, PNAS, vol.100, pp.10158-10163, 2003. ,
Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas, Journal of Medical Genetics, vol.39, pp.178-183, 2002. ,
Application of time-domain fitting in the quantification of in vivo 1 H spectroscopic imaging data sets, NMR in Biomedicine, vol.5, pp.171-178, 1992. ,
Towards hyperpolarized (13)C-succinate imaging of brain cancer, Journal of Magnetic Resonance, vol.186, pp.150-155, 2007. ,
18 F-FDG PET/CT as a predictor of hereditary head and neck paragangliomas, European Journal of Clinical Investigation, vol.44, pp.325-332, 2014. ,
Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors, Radiology, vol.172, pp.541-548, 1989. ,
Whole-exome sequencing identifies MDH2 as a new familial paraganglioma gene, Journal of the National Cancer Institute, vol.107, issue.053, 2015. ,
Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas, Human Molecular Genetics, vol.23, pp.2440-2446, 2014. ,
Adrenal masses: characterization with in vivo proton MR spectroscopy -initial experience, Radiology, vol.245, pp.788-797, 2007. ,
The Warburg effect is genetically determined in inherited pheochromocytomas, PLoS ONE, vol.4, p.7094, 2009. ,
,
, Multimodal MR imaging (diffusion, perfusion, and spectroscopy): is it possible to distinguish oligodendroglial tumor grade and 1p/19q codeletion in the pretherapeutic diagnosis?, AJNR. American Journal of Neuroradiology, vol.34, pp.1326-1333
Isocitrate dehydrogenase mutations are rare in pheochromocytomas and paragangliomas, Journal of Clinical Endocrinology and Metabolism, vol.95, pp.1274-1278, 2010. ,
Proton NMR chemical shifts and coupling constants for brain metabolites, NMR in Biomedicine, vol.13, pp.129-153, 2000. ,
, In Vivo NMR Spectroscopy: Principles and Techniques. Second Edition, 2008.
Aberrant DNA hypermethylation of SDHC: a novel mechanism of tumor development in Carney triad, Endocrine-Related Cancer, vol.21, pp.567-577, 2014. ,
Elevated plasma succinate in PTEN, SDHB, and SDHD mutation-positive individuals, Genetics in Medicine, vol.14, pp.616-619, 2012. ,
A new specific succinate-glutamate metabolomic hallmark in SDHx-related paragangliomas, PLoS ONE, vol.8, p.80539, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01699803
Bachellier P & Namer IJ 2013b Metabolomic profile of the adrenal gland: from physiology to pathological conditions, Endocrine-Related Cancer, vol.20, pp.705-716 ,
Metabolome profiling by HRMAS NMR spectroscopy of pheochromocytomas and paragangliomas detects SDH deficiency: clinical and pathophysiological implications, Neoplasia, vol.17, pp.55-65, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01682749
Namer IJ 2015b In vivo detection of catecholamines by magnetic resonance spectroscopy: a potential specific biomarker for pheochromocytoma diagnosis, Surgery ,
Tumor metabolism and perfusion in head and neck squamous cell carcinoma: pretreatment multimodality imaging with 1 H magnetic resonance spectroscopy, dynamic contrast-enhanced MRI, and [ 18 F]FDG-PET, International Journal of Radiation Oncology, vol.82, pp.299-307, 2012. ,
Breathhold abdominal and thoracic proton MR spectroscopy at 3T. Magnetic Resonance in Medicine, vol.50, pp.461-467, 2003. ,
Characterization of adrenal pheochromocytoma using respiratorytriggered proton MR spectroscopy: initial experience, AJR. American Journal of Roentgenology, vol.192, pp.450-454, 2009. ,
Salivary gland tumors at in vivo proton MR spectroscopy, Radiology, vol.237, pp.563-569, 2005. ,
Monitoring of treatment response after chemoradiotherapy for head and neck cancer using in vivo 1 H MR spectroscopy, European Radiology, vol.20, pp.165-172, 2010. ,
Quantitative 1 H and 31 P MRS of PCA extracts of postmortem Alzheimer's disease brain, Neurobiology of Aging, vol.17, pp.349-357, 1996. ,
Analysis of cancer metabolism by imaging hyperpolarized nuclei: prospects for translation to clinical research, Neoplasia, vol.13, pp.81-97, 2011. ,
, , 2010.
, Grid-free interactive and automated data processing for MR chemical shift imaging data, Magma, vol.23, pp.23-30
Succinate-to-fumarate ratio as a new metabolic marker to detect the presence of SDHB/D-related paraganglioma: initial experimental and ex vivo findings, Endocrinology, vol.155, pp.27-32, 2014. ,
Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment, Current Problems in Cancer, vol.38, pp.7-41, 2014. ,
In vivo detection of brain Krebs cycle intermediate by hyperpolarized magnetic resonance, Journal of Cerebral Blood Flow and Metabolism, vol.32, pp.2108-2113, 2012. ,
An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis, Lancet Oncology, vol.10, pp.764-771, 2009. ,
Clinical predictors for germline mutations in head and neck paraganglioma patients: cost reduction strategy in genetic diagnostic process as fall-out, Cancer Research, vol.69, pp.3650-3656, 2009. ,
Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients, Endocrine-Related Cancer, vol.19, pp.149-155, 2012. ,
, , 2015.
, Genotype-specific differences in the tumor metabolite profile of pheochromocytoma and paraganglioma using untargeted and targeted metabolomics, Journal of Clinical Endocrinology and Metabolism, vol.100, pp.214-222
Time-domain semi-parametric estimation based on a metabolite basis set, NMR in Biomedicine, vol.18, pp.1-13, 2005. ,
URL : https://hal.archives-ouvertes.fr/hal-00443422
Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome, PNAS, vol.108, pp.3270-3275, 2011. ,
Krebs cycle metabolite profiling for identification and stratification of pheochromocytomas/ paragangliomas due to succinate dehydrogenase deficiency, Journal of Clinical Endocrinology and Metabolism, vol.99, pp.3903-3911, 2014. ,
Implications of respiratory motion for the quantification of 2D MR spectroscopic imaging data in the abdomen, Physics in Medicine and Biology, vol.45, pp.2105-2116, 2000. ,
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-a prolyl hydroxylase, Cancer Cell, vol.7, pp.77-85, 2005. ,
Prospective evaluation of in vivo proton MR spectroscopy in differentiation of similar appearing intracranial cystic lesions, Magnetic Resonance Imaging, vol.19, pp.224-231, 2001. ,
18 F-FDG avidity of pheochromocytomas and paragangliomas: a new molecular imaging signature, Journal of Nuclear Medicine, vol.50, pp.711-717, 2009. ,
Current and future trends in the anatomical and functional imaging of head and neck paragangliomas, Seminars in Nuclear Medicine, vol.43, pp.462-473, 2013. ,
Current approaches and recent developments in the management of head and neck paragangliomas, Endocrine Reviews, vol.35, pp.795-819, 2014. ,
Shulkin BL & Pacak K 2014b Renaissance of (18)F-FDG positron emission tomography in the imaging of pheochromocytoma/paraganglioma, Journal of Clinical Endocrinology and Metabolism, vol.99, pp.2337-2339 ,
Staging and functional characterization of pheochromocytoma and paraganglioma by 18 F-fluorodeoxyglucose ( 18 F-FDG) positron emission tomography, Journal of the National Cancer Institute, vol.104, pp.700-708, 2012. ,
Current views on cell metabolism in SDHx-related pheochromocytoma and paraganglioma, Endocrine-Related Cancer, vol.21, pp.261-277, 2014. ,